Performant Healthcare Debt to Equity Ratio 2011-2025 | PHLT
Current and historical debt to equity ratio values for Performant Healthcare (PHLT) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Performant Healthcare debt/equity for the three months ending March 31, 2025 was 0.10.
| Performant Healthcare Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $0.03B | $0.08B | 0.35 |
| 2024-12-31 | $0.03B | $0.08B | 0.33 |
| 2024-09-30 | $0.03B | $0.08B | 0.35 |
| 2024-06-30 | $0.03B | $0.08B | 0.35 |
| 2024-03-31 | $0.02B | $0.08B | 0.28 |
| 2023-12-31 | $0.02B | $0.08B | 0.23 |
| 2023-09-30 | $0.02B | $0.08B | 0.29 |
| 2023-06-30 | $0.02B | $0.08B | 0.29 |
| 2023-03-31 | $0.02B | $0.08B | 0.28 |
| 2022-12-31 | $0.03B | $0.08B | 0.41 |
| 2022-09-30 | $0.03B | $0.08B | 0.41 |
| 2022-06-30 | $0.04B | $0.08B | 0.42 |
| 2022-03-31 | $0.04B | $0.09B | 0.40 |
| 2021-12-31 | $0.04B | $0.08B | 0.48 |
| 2021-09-30 | $0.07B | $0.08B | 0.79 |
| 2021-06-30 | $0.07B | $0.04B | 1.67 |
| 2021-03-31 | $0.09B | $0.04B | 2.29 |
| 2020-12-31 | $0.08B | $0.04B | 2.01 |
| 2020-09-30 | $0.08B | $0.04B | 2.21 |
| 2020-06-30 | $0.08B | $0.04B | 2.33 |
| 2020-03-31 | $0.09B | $0.04B | 2.07 |
| 2019-12-31 | $0.09B | $0.05B | 1.59 |
| 2019-09-30 | $0.09B | $0.06B | 1.57 |
| 2019-06-30 | $0.08B | $0.06B | 1.22 |
| 2019-03-31 | $0.07B | $0.07B | 1.06 |
| 2018-12-31 | $0.06B | $0.08B | 0.78 |
| 2018-09-30 | $0.06B | $0.08B | 0.74 |
| 2018-06-30 | $0.06B | $0.09B | 0.65 |
| 2018-03-31 | $0.06B | $0.09B | 0.64 |
| 2017-12-31 | $0.08B | $0.08B | 1.05 |
| 2017-09-30 | $0.09B | $0.08B | 1.07 |
| 2017-06-30 | $0.09B | $0.08B | 1.05 |
| 2017-03-31 | $0.10B | $0.08B | 1.15 |
| 2016-12-31 | $0.10B | $0.09B | 1.15 |
| 2016-09-30 | $0.12B | $0.10B | 1.22 |
| 2016-06-30 | $0.13B | $0.10B | 1.29 |
| 2016-03-31 | $0.13B | $0.10B | 1.32 |
| 2015-12-31 | $0.15B | $0.09B | 1.58 |
| 2015-09-30 | $0.16B | $0.09B | 1.76 |
| 2015-06-30 | $0.16B | $0.09B | 1.82 |
| 2015-03-31 | $0.17B | $0.09B | 1.96 |
| 2014-12-31 | $0.17B | $0.09B | 1.88 |
| 2014-09-30 | $0.17B | $0.09B | 1.88 |
| 2014-06-30 | $0.16B | $0.09B | 1.83 |
| 2014-03-31 | $0.18B | $0.08B | 2.22 |
| 2013-12-31 | $0.18B | $0.07B | 2.47 |
| 2013-09-30 | $0.19B | $0.07B | 2.90 |
| 2013-06-30 | $0.18B | $0.05B | 3.76 |
| 2013-03-31 | $0.18B | $0.03B | 5.72 |
| 2012-12-31 | $0.19B | $0.02B | 7.80 |
| 2012-09-30 | $0.19B | $0.02B | 10.99 |
| 2012-06-30 | $0.00B | $0.00B | 0.00 |
| 2012-03-31 | $0.00B | $0.00B | 0.00 |
| 2011-12-31 | $0.00B | 0.00 | |
| 2011-09-30 | $0.00B | $0.00B | 0.00 |
| 2010-12-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.269B | $0.123B |
| Performant Financial Corporation is engaged in providing technology-enabled recovery and related analytics services in the United States. The company's services help identify and recover delinquent or defaulted assets and improper payments for both government and private clients. Services offered by the company includes financial asset recovery, risk management, audit and recovery cost containment and fraud, waste and abuse marketplace. Performant provides its services on an outsourced basis. It provides services to clients in a range of different markets which includes student lending and healthcare, delinquent state taxes and federal Treasury and other receivables. Performant Financial Corporation is headquartered in Livermore, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.550B | 26.36 |
| Elevance Health (ELV) | United States | $84.617B | 10.92 |
| CVS Health (CVS) | United States | $84.212B | 10.47 |
| Cencora (COR) | United States | $56.918B | 19.80 |
| Natera (NTRA) | United States | $23.467B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| Solventum (SOLV) | United States | $12.729B | 13.47 |
| CochLear (CHEOY) | Australia | $12.142B | 0.00 |
| ICON (ICLR) | Ireland | $11.829B | 11.00 |
| Revvity (RVTY) | United States | $11.196B | 19.27 |
| Doximity (DOCS) | United States | $10.774B | 49.88 |
| Viatris (VTRS) | United States | $10.411B | 3.58 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $8.892B | 23.62 |
| HealthEquity (HQY) | United States | $8.760B | 38.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.172B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.242B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.149B | 24.44 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.233B | 18.37 |
| Alignment Healthcare (ALHC) | United States | $2.762B | 0.00 |
| Concentras Parent (CON) | United States | $2.658B | 15.36 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| Surgery Partners (SGRY) | United States | $2.473B | 32.17 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.912B | 73.63 |
| Ardent Health (ARDT) | United States | $1.865B | 7.95 |
| Premier (PINC) | United States | $1.816B | 13.79 |
| Progyny (PGNY) | United States | $1.798B | 39.58 |
| GoodRx Holdings (GDRX) | United States | $1.643B | 32.86 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.136B | 8.64 |
| Establishment Labs Holdings (ESTA) | $1.093B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.56 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.873B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.633B | 9.58 |
| Embecta (EMBC) | United States | $0.571B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.525B | 0.00 |
| Enhabit (EHAB) | United States | $0.469B | 38.63 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| SBC Medicals (SBC) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.433B | 0.00 |
| Omada Health (OMDA) | $0.391B | 0.00 | |
| Oncology Institute (TOI) | United States | $0.213B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| DocGo (DCGO) | United States | $0.162B | 26.50 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| So-Young (SY) | China | $0.119B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |